A new medical review published in JAMA Neurology suggests that Lewy body dementia, often called LBD, may be far more common than experts previously believed. The findings gained widespread public attention following the recent death of media pioneer Ted Turner, who had reportedly been living with the disease since 2018.
Researchers now say that Lewy body dementia could occur more frequently than several other rare neurological conditions, including ALS and some forms of Parkinson’s disease. The study highlights the urgent need for better diagnosis, increased awareness, and more specialized care for people experiencing symptoms associated with this complex brain disorder.
Lewy body dementia is a progressive neurological disease linked to abnormal protein deposits in the brain called Lewy bodies. These deposits are made of alpha-synuclein, a protein that interferes with normal brain function.
The disease affects multiple areas of health, including:
People with LBD often experience symptoms that overlap with both Alzheimer’s disease and Parkinson’s disease, making diagnosis especially challenging.
One of the hallmark symptoms of Lewy body dementia is vivid visual hallucinations. Patients may also experience dramatic fluctuations in alertness and attention. In some cases, individuals can appear mentally sharp one moment and severely confused the next.
The evidence review analyzed data from 12 previous studies to estimate how common Lewy body dementia may actually be worldwide.
Researchers found that LBD occurs at a rate of approximately 4.8 cases per 100,000 person years. This makes it more common than several other well known neurodegenerative disorders.
For comparison:
According to the researchers, these findings suggest that Lewy body dementia has likely been underdiagnosed for years.
The study also found that men appear to have slightly higher rates of LBD than women. Male incidence rates were estimated at 5.5 cases per 100,000 person years compared with 4.3 cases among women.
One of the biggest concerns raised by experts is the lack of standardized diagnostic approaches for Lewy body dementia.
Because symptoms can mimic psychiatric disorders, Alzheimer’s disease, or Parkinson’s disease, many patients may not receive accurate diagnoses until the disease has significantly progressed.
Dr. Jeremy Koppel, co director of the Litwin Zucker Research Center for the Study of Alzheimer’s Disease in New York, explained that patients with LBD frequently present with psychiatric symptoms before major cognitive decline becomes obvious.
These symptoms can include:
This overlap can lead healthcare providers to initially suspect mental health disorders rather than a neurological disease.
Experts say improved physician education and better diagnostic tools are critical to reducing underdiagnosis and misclassification.
The public disclosure of Ted Turner’s diagnosis has sparked renewed conversation about Lewy body dementia and its impact on patients and families.
Awareness from high profile cases often helps encourage earlier recognition of symptoms and promotes public understanding of lesser known medical conditions.
Healthcare experts hope Turner’s story will encourage more conversations about cognitive health and help clinicians identify warning signs sooner.
Increased awareness may also support future funding for neurological research and caregiver resources.
Although there is currently no cure for Lewy body dementia, early diagnosis can help improve quality of life and symptom management.
Treatment often includes a combination of:
However, specialists warn that people with LBD can react very differently to medications commonly prescribed for other forms of dementia.
According to Dr. Koppel, antipsychotic medications can sometimes trigger severe or dangerous reactions in patients with Lewy body dementia. This makes accurate diagnosis even more important before treatment begins.
Doctors typically recommend personalized treatment plans designed around each patient’s symptoms and medical history.
Recognizing the early warning signs of Lewy body dementia may help families seek medical evaluation sooner.
Common symptoms include:
Symptoms often fluctuate from day to day, which can make the disease difficult to recognize in its early stages.
As researchers continue studying Lewy body dementia, experts emphasize the need for:
With aging populations worldwide, neurodegenerative diseases are expected to become an increasingly important public health issue in the coming decades.
The latest findings may help healthcare systems better understand the true impact of Lewy body dementia and encourage more comprehensive patient care.
The new review published in JAMA Neurology highlights an important shift in how experts view Lewy body dementia. Once considered relatively uncommon, the disease may actually affect far more people than previously estimated.
The condition remains difficult to diagnose due to overlapping psychiatric and neurological symptoms, but increased awareness could lead to earlier intervention and safer treatment strategies.
Ted Turner’s public journey with Lewy body dementia has also brought much needed attention to a disease that often remains misunderstood. As medical experts continue researching LBD, patients and families may benefit from improved recognition, better support systems, and more targeted care in the future.
This article is for informational and educational purposes only and should not be considered medical advice. The information provided does not replace professional diagnosis, treatment, or consultation with a qualified healthcare provider. Always seek medical advice from your physician or another licensed healthcare professional regarding any medical condition or health concern.
Most Accurate Healthcare AI designed for everything from admin workflows to clinical decision support.